EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Sequence of antihypertensive medications used in preterm infants with hypertension: A cross-sectional study

Alejandro D Perez iD, Mary-Carty Pittman, Kaniz Afroz Tanni, Keia R Sanderson, Jieun Park iD, Daniel I Feig, Matthew M Laughon, Matthew Shane Loop iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0320002 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift PLOS One, 2025. Verfasst von Alejandro D Perez und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill,…. Hauptthemen laut MEDLINE: Antihypertensive Agents, Infant, Premature, Hypertension. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hypertension in preterm infants can result in life-threatening outcomes. However, there is limited evidence to guide the pharmacologic management of hypertension in preterm infants. Without population-level studies of the pharmacologic strategies that clinicians currently employ for hypertension in preterm infants, studies investigating the benefits and risks of these strategies cannot be performed.

Methods

A retrospective, cross-sectional study was conducted at a single academic medical centerto determine the most prevalent antihypertensive medication used for first-line, second-line, and adjunctive pharmacologic management among preterm infants with hypertension. The study sample included patients with a postnatal age less than 1 year at hospital discharge, gestational age at birth less than 37 weeks, and treated with an antihypertensive medication between July 2010 and December 2022. The prevalence of each antihypertensive medication used for each stage of pharmacologic management was estimated, and prevalences were compared using prevalence ratios. Bayesian multinomial regression was used to estimate prevalence ratios and 95% credible intervals (CIs).

Results

Out of 751 possibly eligible patient encounters obtained, 134 encounters were identified across 120 patients that met the inclusion criteria. Second-line and adjunctive pharmacologic management were used in 6 and 12 encounters, respectively. Propranolol had the highest prevalence for each stage of pharmacologic management: 61% for first-line (95% CI: 53-69%); 40% for second-line (95% CI: 14-70%); and 47% for adjunctive pharmacologic management (95% CI: 24-72%). As a first-line pharmacologic management, propranolol was 4.8 times (95% CI: 2.9-7.7) as prevalent as the second most prevalent medication (captopril).

Conclusion

In a large academic hospital, propranolol was the most commonly used medication for first-line antihypertensive pharmacologic management among preterm infants. The most prevalent medication used for second-line and adjunctive pharmacologic management was inconclusive.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antihypertensive AgentsInfant, PrematureHypertensionHumansCross-Sectional StudiesInfant, NewbornFemaleMaleRetrospective StudiesPrevalencePropranololGestational AgeInfant

Substanzen

Antihypertensive AgentsPropranolol

Autor:innen und Institutionen

  • Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Department of Health Outcomes Research and Policy, Harrison College of Pharmacy, Auburn University, Auburn, Alabama, United States of America.
  • Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Harrison College of Pharmacy, Auburn University, Auburn, Alabama, United States of America.
  • Department of Pediatrics, Marnix E. Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
  • Division of Neonatal-Perinatal Medicine, Department of Pediatrics, University of North Carolina School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.

ORCID-Profile: Alejandro D Perez, Jieun Park, Matthew Shane Loop

Förderung

  • NCATS NIH HHS
  • National Center for Advancing Translational Sciences

Zitieren

APA

Perez, A. D., Pittman, M. C., Afroz Tanni, K., Sanderson, K. R., Park, J., Feig, D. I., Laughon, M. M., & Loop, M. S. (2025). Sequence of antihypertensive medications used in preterm infants with hypertension: A cross-sectional study. PLOS One. https://doi.org/10.1371/journal.pone.0320002

Vancouver

Perez AD, Pittman MC, Afroz Tanni K, Sanderson KR, Park J, Feig DI, et al. Sequence of antihypertensive medications used in preterm infants with hypertension: A cross-sectional study. PLOS One. 2025. doi:10.1371/journal.pone.0320002

BibTeX
@article{Perez2025,
  author = {Perez, Alejandro D and Pittman, Mary-Carty and Afroz Tanni, Kaniz and Sanderson, Keia R and Park, Jieun and Feig, Daniel I and Laughon, Matthew M and Loop, Matthew Shane},
  title = {Sequence of antihypertensive medications used in preterm infants with hypertension: A cross-sectional study},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0320002}
}
Kostenlos starten →